Michael Coyle, the president of Medtronic’s cardiovascular business, is leaving the company to become the CEO of digital health company iRhythm at the end of December.
Sean Salmon, currently the president of Medtronic’s diabetes business will become president of Medtronic’s cardiovascular business, effective 1 January, while...






